Cargando…

Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma

BACKGROUND: Although asbestos acts as a potent carcinogen in pleural mesothelial and pulmonary epithelial cells, it still remains unclear whether asbestos causes specific and characteristic gene alterations in these different kinds of target cells, because direct comparison in an identical patient i...

Descripción completa

Detalles Bibliográficos
Autores principales: Naka, Tomoaki, Hatanaka, Yutaka, Marukawa, Katsuji, Okada, Hiromi, Hatanaka, Kanako C., Sakakibara-Konishi, Jun, Oizumi, Satoshi, Hida, Yasuhiro, Kaga, Kichizo, Mitsuhashi, Tomoko, Matsuno, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836188/
https://www.ncbi.nlm.nih.gov/pubmed/27091358
http://dx.doi.org/10.1186/s13000-016-0488-0
_version_ 1782427727126593536
author Naka, Tomoaki
Hatanaka, Yutaka
Marukawa, Katsuji
Okada, Hiromi
Hatanaka, Kanako C.
Sakakibara-Konishi, Jun
Oizumi, Satoshi
Hida, Yasuhiro
Kaga, Kichizo
Mitsuhashi, Tomoko
Matsuno, Yoshihiro
author_facet Naka, Tomoaki
Hatanaka, Yutaka
Marukawa, Katsuji
Okada, Hiromi
Hatanaka, Kanako C.
Sakakibara-Konishi, Jun
Oizumi, Satoshi
Hida, Yasuhiro
Kaga, Kichizo
Mitsuhashi, Tomoko
Matsuno, Yoshihiro
author_sort Naka, Tomoaki
collection PubMed
description BACKGROUND: Although asbestos acts as a potent carcinogen in pleural mesothelial and pulmonary epithelial cells, it still remains unclear whether asbestos causes specific and characteristic gene alterations in these different kinds of target cells, because direct comparison in an identical patient is not feasible. We experienced a rare synchronous collision tumor composed of malignant pleural mesothelioma (MPM) and primary pulmonary adenocarcinoma (PAC) in a 77-year-old man with a history of long-term smoking and asbestos exposure, and compared the DNA copy number alteration (CNA) and somatic mutation in these two independent tumors. METHODS: Formalin-fixed paraffin-embedded (FFPE) tissues of MPM and PAC lesions from the surgically resected specimen were used. Each of these MPM and PAC lesions exhibited a typical histology and immunophenotype. CNA analysis using SNP array was performed using the Illumina Human Omni Express-12_FFPE (Illumina, San Diego, CA, USA) with DNA extracts from each lesion. Somatic mutation analysis using next-generation sequencing was performed using the TruSeq Amplicon Cancer Panel (Illumina). RESULTS: The CNA analysis demonstrated a marked difference in the frequency of gain and loss between MPM and PAC. In PAC, copy number (CN) gain was detected more frequently and widely than CN loss, whereas in MPM there was no such obvious difference. PAC did not harbor CNAs that have been identified in asbestos-associated lung cancer, but did harbor some of the CNAs associated with smoking. MPM exhibited CN loss at 9p21.2-3, which is the most common genetic alteration in mesothelioma. CONCLUSION: In this particular case, asbestos exposure may not have played a primary role in PAC carcinogenesis, but cigarette smoking may have contributed more to the occurrence of CN gains in PAC. This comparative genetic analysis of two different lesions with same amount of asbestos exposure and cigarette smoke exposure has provided information on differences in the cancer genome related to carcinogenesis.
format Online
Article
Text
id pubmed-4836188
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48361882016-04-20 Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma Naka, Tomoaki Hatanaka, Yutaka Marukawa, Katsuji Okada, Hiromi Hatanaka, Kanako C. Sakakibara-Konishi, Jun Oizumi, Satoshi Hida, Yasuhiro Kaga, Kichizo Mitsuhashi, Tomoko Matsuno, Yoshihiro Diagn Pathol Case Report BACKGROUND: Although asbestos acts as a potent carcinogen in pleural mesothelial and pulmonary epithelial cells, it still remains unclear whether asbestos causes specific and characteristic gene alterations in these different kinds of target cells, because direct comparison in an identical patient is not feasible. We experienced a rare synchronous collision tumor composed of malignant pleural mesothelioma (MPM) and primary pulmonary adenocarcinoma (PAC) in a 77-year-old man with a history of long-term smoking and asbestos exposure, and compared the DNA copy number alteration (CNA) and somatic mutation in these two independent tumors. METHODS: Formalin-fixed paraffin-embedded (FFPE) tissues of MPM and PAC lesions from the surgically resected specimen were used. Each of these MPM and PAC lesions exhibited a typical histology and immunophenotype. CNA analysis using SNP array was performed using the Illumina Human Omni Express-12_FFPE (Illumina, San Diego, CA, USA) with DNA extracts from each lesion. Somatic mutation analysis using next-generation sequencing was performed using the TruSeq Amplicon Cancer Panel (Illumina). RESULTS: The CNA analysis demonstrated a marked difference in the frequency of gain and loss between MPM and PAC. In PAC, copy number (CN) gain was detected more frequently and widely than CN loss, whereas in MPM there was no such obvious difference. PAC did not harbor CNAs that have been identified in asbestos-associated lung cancer, but did harbor some of the CNAs associated with smoking. MPM exhibited CN loss at 9p21.2-3, which is the most common genetic alteration in mesothelioma. CONCLUSION: In this particular case, asbestos exposure may not have played a primary role in PAC carcinogenesis, but cigarette smoking may have contributed more to the occurrence of CN gains in PAC. This comparative genetic analysis of two different lesions with same amount of asbestos exposure and cigarette smoke exposure has provided information on differences in the cancer genome related to carcinogenesis. BioMed Central 2016-04-18 /pmc/articles/PMC4836188/ /pubmed/27091358 http://dx.doi.org/10.1186/s13000-016-0488-0 Text en © Naka et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Naka, Tomoaki
Hatanaka, Yutaka
Marukawa, Katsuji
Okada, Hiromi
Hatanaka, Kanako C.
Sakakibara-Konishi, Jun
Oizumi, Satoshi
Hida, Yasuhiro
Kaga, Kichizo
Mitsuhashi, Tomoko
Matsuno, Yoshihiro
Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
title Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
title_full Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
title_fullStr Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
title_full_unstemmed Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
title_short Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
title_sort comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836188/
https://www.ncbi.nlm.nih.gov/pubmed/27091358
http://dx.doi.org/10.1186/s13000-016-0488-0
work_keys_str_mv AT nakatomoaki comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT hatanakayutaka comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT marukawakatsuji comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT okadahiromi comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT hatanakakanakoc comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT sakakibarakonishijun comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT oizumisatoshi comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT hidayasuhiro comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT kagakichizo comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT mitsuhashitomoko comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma
AT matsunoyoshihiro comparativegeneticanalysisofararesynchronouscollisiontumorcomposedofmalignantpleuralmesotheliomaandprimarypulmonaryadenocarcinoma